| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows provided by investing activities | 75,872 | 46,854 |
| Proceeds from sales of class a ordinary shares, net of offering costs | 7,102 | 0 |
| Payments on finance leases | 21 | 26 |
| Exercise of stock options | 854 | - |
| Net cash flows (used in) provided by financing activities | 7,935 | -26 |
| Net change in cash and cash equivalents | -3,797 | -14,180 |
| Cash and cash equivalents at beginning of period | 99,120 | - |
| Cash and cash equivalents at end of period | 95,323 | - |
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)